Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Cited by (827)

Items 201–300 of 827

1. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation
   Julie Leclerc, Cathy Flament, Tonio Lovecchio, Lucie Delattre, Emilie Ait‐Yahya, Stéphanie Baert‐Desurmont, Nelly Burnichon, Myriam Bronner, Odile Cabaret, Sophie Lejeune et al. · 2018 · Genetics in Medicine
2. Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing
   Erika Marie. Hissong, Elizabeth P. Crowe, Rhonda K. Yantiss, Yao‐Tseng Chen · 2018 · Modern Pathology
3. Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer
   Ramprasath Venkatachalam, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Hans K. Schackert, Heike Görgens, Marc‐Manuel Hahn, Eveline J. Kamping, Lilian Vreede, Eveline Hoenselaar, Erica van der Looij et al. · 2010 · Gastroenterology
4. Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes
   Qing Wang · 2015 · Acta Pharmacologica Sinica
5. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome
   Léa Rossi, Marie‐Aude Le Frère‐Belda, Pierre Laurent‐Puig, Bruno Buecher, Antoine De Pauw, Dominique Stoppa‐Lyonnet, Geoffroy Canlorbe, Olivier Caron, Bruno Borghese, Chrystelle Colas et al. · 2017 · International Journal of Gynecological Cancer
6. Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
   Xinyu Ren, Yu Min Song, Jing Wang, Long-yun Chen, Junyi Pang, Liangrui Zhou, Song-jie Shen, Xi Cao, Yuxin Wang, Miao-miao Shao et al. · 2021 · Frontiers in Oncology
7. Lynch syndrome, molecular mechanisms and variant classification
   Amanda B. Abildgaard, Sofie Vincents Nielsen, Inge Bernstein, Amelie Stein, Kresten Lindorff‐Larsen, Rasmus Hartmann‐Petersen · 2022 · British Journal of Cancer
8. Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy
   Alexandra Kavun, Egor Veselovsky, Alexandra Lebedeva, Ekaterina Belova, Olesya A. Kuznetsova, Valentina D. Yakushina, Tatiana V. Grigoreva, Vladislav Mileyko, Mikhail Yu. Fedyanin, Maxim V. Ivanov · 2023 · Cancers
9. Synchronized long-read genome, methylome, epigenome and transcriptome profiling resolve a Mendelian condition
   Mitchell Robert Vollger, Jonas Korlach, Kiara C. Eldred, Elliott G. Swanson, Jason G. Underwood, Stephanie C. Bohaczuk, Yizi Mao, Yong-Han Hank Cheng, Jane E. Ranchalis, Elizabeth Blue et al. · 2025 · Nature Genetics
10. L ynch‐like syndrome: Characterization and comparison with EPCAM deletion carriers
    So Young Kang, Cheol Keun Park, Dong Kyung Chang, Jong‐Won Kim, Hee Jung Son, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Moosik Kwon, Kyoung‐Mee Kim · 2014 · International Journal of Cancer
11. Epigenetic biomarkers in colorectal cancer diagnostics
    James B. Rawson, Bharati V. Bapat · 2012 · Expert Review of Molecular Diagnostics
12. Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?
    Fränzel J.B. van Duijnhoven, Akke Botma, Renate M. Winkels, Fokko M. Nagengast, Hans F. A. Vasen, Ellen Kampman · 2013 · Familial Cancer
13. Physical activity and the risk of colorectal cancer in Lynch syndrome
    S. Ghazaleh Dashti, Aung Ko Win, Sheetal S. Hardikar, Stephen E. Glombicki, Sheila Mallenahalli, Selvi Thirumurthi, Susan K. Peterson, Y. Nancy You, Daniel D. Buchanan, Jane C. Figueiredo et al. · 2018 · International Journal of Cancer
14. Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: A Systematic Review
    Anne M.L. Jansen, Ajay Goel · 2020 · Clinical Gastroenterology and Hepatology
15. Analysis of EPCAM Protein Expression in Diagnostics of Lynch Syndrome
    Matthias Kloor, Anita Yvonne Voigt, Hans K. Schackert, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker · 2010 · Journal of Clinical Oncology
16. Natural Antisense Transcripts at the Interface between Host Genome and Mobile Genetic Elements
    Hany S. Zinad, Inas Natasya, Andreas Werner · 2017 · Frontiers in Microbiology
17. Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?
    Laëtitia Nebot-Bral, Clélia Coutzac, Patricia L Kannouche, Nathalie Chaput · 2018 · Bulletin du Cancer
18. Lynch syndrome for the gynaecologist
    Neil A. J. Ryan, R F McMahon, Neal C. Ramchander, Mourad W. Seif, D. Gareth Evans, Emma Jayne Crosbie · 2020 · The Obstetrician & Gynaecologist
19. The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype
    Chau‐To Kwok, Ingrid P. Vogelaar, Wendy A. van Zelst-Stams, Arjen R. Mensenkamp, Marjolijn J. L. Ligtenberg, Robert W. Rapkins, Robyn Lynne Ward, Nicolette M. Chun, James M. Ford, Uri Ladabaum et al. · 2013 · European Journal of Human Genetics
20. Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes
    Orli Michaeli, Uri Y. Tabori · 2018 · Journal of Korean Neurosurgical Society
21. Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases
    James Mueller, Isabella Gazzoli, Prathap Bandipalliam, Judy Ellen Garber, Sapna Syngal, Richard David Kolodner · 2009 · Cancer Research
22. Universal Immunohistochemistry for Lynch Syndrome: A Systematic Review and Meta-analysis of 58,580 Colorectal Carcinomas
    Ellis L. Eikenboom, A. Lam, Mar Rodríguez‐Girondo, Christie J. van Asperen, Winand N.M. Dinjens, Robert M.W. Hofstra, Monique Esther van Leerdam, Hans M. Morreau, Manon C.W. Spaander, Anja Wagner et al. · 2021 · Clinical Gastroenterology and Hepatology
23. Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal Cancer
    Mathew A. Sloane, Andrea C. Nunez, Deborah Packham, Chau‐To Kwok, Graeme Suthers, Luke B. Hesson, Robyn Lynne Ward · 2015 · JAMA Oncology
24. Epigenetic Regulation and Colorectal Cancer
    Nagahide Matsubara · 2011 · Diseases of the Colon & Rectum
25. Epigenetics and Genetics in Endometrial Cancer: New Carcinogenic Mechanisms and Relationship with Clinical Practice
    Kouji Banno, Iori Kisu, Megumi Yanokura, Kenta Masuda, Arisa Ueki, Yusuke Kobayashi, Nobuyuki Susumu, Daisuke Aoki · 2012 · Epigenomics
26. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives
    Aung Ko Win, Daniel D. Buchanan, Christophe Rosty, Robert J. MacInnis, James G. Dowty, Gillian S. Dite, Graham G. Giles, Melissa C. Southey, Joanne P Young, Mark Clendenning et al. · 2014 · Gut
27. MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
    Bente A. Talseth‐Palmer, Mary L. McPhillips, Claire Groombridge, Allan D. Spigelman, Rodney John Scott · 2010 · Hereditary Cancer in Clinical Practice
28. Regulation of the Function and Expression of EpCAM
    Di Xiao, Mingrui Xiong, Xin Wei Wang, Mengqing Lyu, Hanxiang Sun, Yeting Cui, Chen Chen, Ziyu Jiang, Fan Sun · 2024 · Biomedicines
29. Clinical Genetics of Hereditary Colorectal Cancer
    Derek Gerard Power, Emily Glogowski, Steven M. Lipkin · 2010 · Hematology/Oncology Clinics of North America
30. Hereditary Colon Cancer: Lynch Syndrome
    Eun Jeong Jang, Daniel C. Chung · 2010 · Gut and Liver
31. Dietary patterns and colorectal adenomas in Lynch syndrome
    Akke Botma, Hans F. A. Vasen, Fränzel J.B. van Duijnhoven, Jan H. Kleibeuker, Fokko M. Nagengast, Ellen Kampman · 2012 · Cancer
32. Molecular Testing in Colorectal Cancer
    Chanjuan Shi, Kay M. Washington · 2012 · American Journal of Clinical Pathology
33. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation
    Megan Philippa Hitchins · 2016 · Familial Cancer
34. Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
    Sigurdís Haraldsdóttir, Heather Hampel, Christina Sing-Ying Wu, Daniel Y. Weng, Peter G. Shields, Wendy L. Frankel, Xueliang Jeff Pan, Albert de la Chapelle, Richard M. Goldberg, Tanios Bekaii‐Saab · 2016 · Genetics in Medicine
35. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience
    Zhaohui Jin, Cristobal T. Sanhueza, Benny Johnson, David M. Nagorney, David W. Larson, Kristin C. Mara, William Harmsen, Thomas C. Smyrk, Axel AG Grothey, Joleen Marie Hubbard · 2018 · The Oncologist
36. Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer
    Jane Varkey Thomas, Alexis Diane Leal, Michael James Overman · 2020 · Clinical Colorectal Cancer
37. Gut γδ T cells as guardians, disruptors, and instigators of cancer
    Toshiyasu Suzuki, Liam Hayman, Anna Kilbey, Joanne Edwards, Seth B. Coffelt · 2020 · Immunological Reviews
38. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP
    Lasse S. Kristensen, Helene Myrtue Nielsen, Henrik Hager, Lise Lotte Hansen · 2010 · Lung Cancer
39. Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences
    Shipra Bhatia, Dirk A. Kleinjan · 2014 · Human Genetics
40. Lynch or Not Lynch? Is that Always a Question?
    Chrystelle Colas, Florence Coulet, Magali Svrcek, Ada Collura, Jean–François Fléjou, Alex Duval, Richard Hamelin · 2012 · Advances in cancer research
41. General lessons from large‐scale studies to identify human cancer predisposition genes
    Jean‐Baptiste Cazier, Ian P.M. Tomlinson · 2009 · The Journal of Pathology
42. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery
    Marc‐Manuel Hahn, Richarda M. de Voer, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Roland P. Kuiper, Ad Geurts van Kessel · 2016 · Cellular Oncology
43. Do alcoholic beverages, obesity and other nutritional factors modify the risk of familial colorectal cancer? A systematic review
    Anthony Fardet, Nathalie Druesne‐Pecollo, Mathilde Touvier, Paule Latino‐Martel · 2017 · Critical Reviews in Oncology/Hematology
44. Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations
    Natasha Caminsky, Eliseos J. Mucaki, Ami M. Perri, Ruipeng Lu, Joan H.M. Knoll, Peter K. Rogan · 2016 · Human Mutation
45. The molecular basis of α-thalassemia: a model for understanding human molecular genetics.
    D. Higgs, R. Gibbons · 2010 · Hematology/Oncology Clinics of North America
46. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients
    Kai Zheng, Hua Wan, Jie Zhang, Guangyu Shan, Ningning Chai, Dongdong Li, Nan Fang, Lina Liu, Jingbo Zhang, Rong Du et al. · 2020 · Journal of Translational Medicine
47. Genetics Talks to Epigenetics? The Interplay Between Sequence Variants and Chromatin Structure
    Silvio Zaina, Elva Leticia Pérez-Luque, Gertrud Lund · 2010 · Current Genomics
48. The Mystery of Mismatch Repair Deficiency: Lynch or Lynch-like?
    Clement Richard Boland · 2013 · Gastroenterology
49. Frequency of Rearrangements in Lynch Syndrome Cases Associated with MSH2 : Characterization of a New Deletion Involving both EPCAM and the 5′ Part of MSH2
    Lucía Pérez‐Cabornero, Mar Infante, Eladio A. Velasco, Enrique Lastra Aras, Alberto Acedo, Cristina Miner Pino, Mercedes Durán Domínguez · 2011 · Cancer Prevention Research
50. The role of epigenetics in colorectal cancer
    Fabio Coppedè · 2014 · Expert Review of Gastroenterology & Hepatology
51. From APC to the genetics of hereditary and familial colon cancer syndromes
    Alisa Petriina Olkinuora, Païvi Peltomäki, Lauri A. Aaltonen, Kristiina Rajamäki · 2021 · Human Molecular Genetics
52. Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing
    Niall Keegan, Steve Donald Wilton, Sue Fletcher · 2022 · Frontiers in Genetics
53. Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review
    Ji Hyun Park, Eun Young Kim, Claudio Luchini, Albino Eccher, Kalthoum Tizaoui, Jae Il Shin, Beom Jin Lim · 2022 · International Journal of Molecular Sciences
54. The changing landscape of Lynch syndrome due to PMS2 mutations
    Jessa Blount, Aishwarya Prakash · 2017 · Clinical Genetics
55. Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
    Anthony J. Scott, Felicia Hernandez, Adam C. Chamberlin, Cathy Smith, Rachid Karam, Jacob Otto Kitzman · 2022 · Genome biology
56. The epigenetics of (hereditary) colorectal cancer
    Ramprasath Venkatachalam, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Diederik R.H. de Bruijn, Roland P. Kuiper, Ad Geurts van Kessel · 2010 · Cancer Genetics and Cytogenetics
57. Detection of genetic alterations in hereditary colorectal cancer screening
    Marta Pineda, Sara González, Conxi Lázaro, Ignacio Blanco, Gabriel Capellá · 2009 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
58. EPCAM Germ Line Deletions as Causes of Lynch Syndrome in Spanish Patients
    Carla Guarinós, Adela Castillejo, Víctor Manuel Barberá, Lucía Pérez–Carbonell, Ana Beatriz Sánchez‐Heras, Ángel Segura, Carmen Guillén‐Ponce, Ana Martínez-Cantó, M.I. Castillejo, Cecilia M. Egoavil et al. · 2010 · Journal of Molecular Diagnostics
59. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome
    Felipe Cavalcanti Carneiro da Silva, José Roberto de Oliveira Ferreira, Giovana Tardin Torrezan, Márcia Cristina Pena Figueiredo, Érika Maria Monteiro Santos, Wilson Toshihiko Nakagawa, Rafael Canfield Brianese, Ligia P. Oliveira, Maria Dirlei Begnani, Samuel Aguiar-Junior et al. · 2015 · PLoS ONE
60. Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
    Amelia Barcellini, Andrea Peloso, Luigi Pugliese, Viviana Vitolo, Lorenzo Cobianchi · 2020 · OncoTargets and Therapy
61. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium
    Teri A. Longacre, Russell R. Broaddus, Linus T Chuang, Michael B. Cohen, Elke A. Jarboe, George L. Mutter, Christopher N. Otis, Richard J. Zaino · 2017 · Archives of Pathology & Laboratory Medicine
62. Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers
    Bente A. Talseth‐Palmer, Juul Wijnen, Ingvild Synnøve Brenne, Shantie Jagmohan–Changur, Daniel Barker, Katie A. Ashton, Carli M.J. Tops, Tiffany‐Jane Evans, Mary L. McPhillips, Claire Groombridge et al. · 2012 · International Journal of Cancer
63. Hypermethylation ofDAPK1is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma
    Lasse S. Kristensen, Fazila Asmar, Konstantinos Dimopoulos, Mette Kathrine Nygaard, Derya Aslan, Jakob Werner Hansen, Elisabeth Methner Ralfkiaer, Kirsten Grønbæk · 2014 · Oncotarget
64. Current clinical topics of Lynch syndrome
    Kohji Tanakaya · 2018 · International Journal of Clinical Oncology
65. Constitutional Mosaic Epimutations – a hidden cause of cancer?
    Per Eystein Lønning, Hans Petter Eikesdal, Inger Marie Løes, Stian Knappskog · 2019 · Cell Stress
66. Clinical Updates and Surveillance Recommendations for DNA Replication Repair Deficiency Syndromes in Children and Young Adults
    Anirban Das, Suzanne P. MacFarland, Julia C. Meade, Jordan R. Hansford, Kami Wolfe Schneider, Roland P. Kuiper, Marjolijn C.J. Jongmans, Harry Layton Lesmana, Kris Ann P. Schultz, Kim E. Nichols et al. · 2024 · Clinical Cancer Research
67. New genes emerging for colorectal cancer predisposition
    Clara Esteban-Jurado · 2014 · World Journal of Gastroenterology
68. Transcriptional and Posttranscriptional Programming by Long Noncoding RNAs
    Radha Raman Pandey, Chandrasekhar Kanduri · 2010 · Progress in molecular and subcellular biology
69. Immunohistochemical Pitfalls
    Michael Markow, Wei Chen, Wendy L. Frankel · 2017 · Surgical pathology clinics
70. DNA methylation as a promising landscape: A simple blood test for breast cancer prediction
    Golnaz Khakpour, Arash Pooladi, Pantea Izadi, Mehrdad Noruzinia, Javad Tavakkoly‐Bazzaz · 2015 · Tumor Biology
71. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: A comprehensive analysis of 3,671 families
    Verena Steinke, Stefanie Holzapfel, Markus Loeffler, Elke Holinski‐Feder, Monika Morak, Hans K. Schackert, Heike Görgens, Christian Peter Pox, Brigitte Royer‐Pokora, Magnus von Knebel Doeberitz et al. · 2013 · International Journal of Cancer
72. Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort†
    Megan Philippa Hitchins, Scott Owens, C-T Kwok, Grant Godsmark, U. Algar, Raj Ramesar · 2011 · Clinical Genetics
73. Criteria and prediction models for mismatch repair gene mutations: a review
    Aung Ko Win, Robert J. MacInnis, James G. Dowty, Mark A. Jenkins · 2013 · Journal of Medical Genetics
74. Anticipation in Lynch Syndrome: Where We Are Where We Go
    Cristina Bozzao, Patrizia Lastella, Alessandro Stella · 2011 · Current Genomics
75. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
    Nisreen Al‐Moghrabi, Maram Al‐Showimi, Nujoud Al‐Yousef, Bushra Alshahrani, Bedri Karakas, Lamyaa Alghofaili, Hannah Faisal Almubarak, Safia Madkhali, Hind Al Humaidan · 2018 · Clinical Epigenetics
76. Emerging role of precision medicine in biliary tract cancers
    James M. Bogenberger, Thomas DeLeon, Mansi Arora, Daniel H. Ahn, Mitesh J. Borad · 2018 · npj Precision Oncology
77. Approaches to diagnose DNA mismatch repair gene defects in cancer
    Javier Peña-Dı́az, Lene Juel Rasmussen · 2015 · DNA repair
78. Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement
    LaFlamme, Christy W., Rastin, Cassandra, Sengupta, Soham, Pennington, Helen E., Russ-Hall, Sophie J., Schneider, Amy L., Bonkowski, Emily S., Almanza Fuerte, Edith P., Allan, Talia J., Zalusky, Miranda Perez-Galey et al. · 2024 · Nature Communications
79. Therapeutic targeting of mismatch repair-deficient cancers
    Paul M. Johannet, Benoı̂t Rousseau, Carol A Aghajanian, Michael Bonner Foote, Luis Alberto Diaz · 2025 · Nature Reviews Clinical Oncology
80. Application of molecular diagnostics for the detection of Lynch syndrome
    Maria Simona Pino, Daniel C. Chung · 2010 · Expert Review of Molecular Diagnostics
81. Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge
    Henry T. Lynch, Stephen J. Lanspa, Trudy G. Shaw, Murray Joseph Casey, Marc Rendell, Mark L. Stacey, Theresa A. Townley, Carrie Snyder, Megan Philippa Hitchins, Joan Wilson · 2017 · Familial Cancer
82. Current View on EpCAM Structural Biology
    Aljaž Gaber, Brigita Lenar≷cic̆, Miha Pavšič · 2020 · Cells
83. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma
    Koo Han Yoo, Yong-Koo Park, Hyun-Sook Kim, Woon‐Won Jung, Sung‐Goo Chang · 2010 · Pathology International
84. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary
    J. Papp, Marietta Eva Kovacs, Zoltán Mátrai, Enikő Orosz, Miklós Kásler, Anne‐Lise Børresen‐Dale, Edith Oláh · 2015 · Familial Cancer
85. Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
    Kouji Banno, Iori Kisu, Megumi Yanokura, Kenta Masuda, Yusuke Kobayashi, Arisa Ueki, Kosuke Tsuji, Wataru Yamagami, Hiroyuki Nomura, Nobuyuki Susumu et al. · 2012 · Biochemistry Research International
86. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression
    Satu Mäki‐Nevala, Satu Valo, Ari P. Ristimaki, Virinder Kaur Sarhadi, Sakari Knuutila, Minna Nyström, Laura Renkonen‐Sinisalo, Anna Lepistö, Jukka‐Pekka Mecklin, Païvi Peltomäki · 2018 · EBioMedicine
87. Long Noncoding RNA and Epigenomics
    Chandrasekhar Kanduri · 2011 · Advances in experimental medicine and biology
88. Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
    Bente A. Talseth‐Palmer, Denis C. Bauer, Wenche Sjursen, Tiffany J. Evans, Mary L. McPhillips, Anthony M. Proietto, Geoffrey R. Otton, Allan D. Spigelman, Rodney John Scott · 2016 · Cancer Medicine
89. Intensity‐dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles
    Jessie Auclair, Thomas Vaissière, Françoise Desseigne, Christine Lasset, Valérie Bonadona, Sophie Giraud, Jean‐Christophe Saurin, Marie‐Odile Joly, Dominique Leroux, Laurence Olivier Faivre et al. · 2010 · Genes Chromosomes and Cancer
90. Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment
    Manel Albertí‐Valls, Sara Olave, Anna Olomí, Anna Macià, Núria Eritja · 2024 · Cancers
91. DNA mismatch repair enzymes: Genetic defects and autoimmunity
    Yoshinao Muro, Kazumitsu Sugiura, Tsuneyo Mimori, Masashi Akiyama · 2015 · Clinica Chimica Acta
92. Revealing the human mutome
    Jian‐Min Chen, Claude Férec, D.N. Cooper · 2010 · Clinical Genetics
93. Recent discoveries in the molecular genetics of Lynch syndrome
    Clement Richard Boland · 2016 · Familial Cancer
94. Assessment of tumor suppressor promoter methylation in healthy individuals
    Deepak Balakrishnan Poduval, Elisabet Ognedal, Zuzana Sichmanova, Eivind Valen, Gjertrud T. Iversen, Laura Minsaas, Per Eystein Lønning, Stian Knappskog · 2020 · Clinical Epigenetics
95. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study
    Ellis L. Eikenboom, Sarah Moen, Monique Esther van Leerdam, Grigorios Papageorgiou, Michail Doukas, Pieter Job Tanis, Evelien Dekker, Anja Wagner, Manon C.W. Spaander · 2023 · The Lancet. Gastroenterology & hepatology
96. Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective
    Aisha S. Sie, Arjen R. Mensenkamp, Eddy Adang, M.J.L. Ligtenberg, Nicoline Hoogerbrugge · 2014 · Annals of Oncology
97. Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events
    Tomasz Kazimierz Wojdacz, Britta Boserup Thestrup, Jens Overgaard, Lise Lotte Hansen · 2011 · Diagnostic Pathology
98. Overexpression of KLHL23 protein from read‐through transcription of PHOSPHO2‐KLHL23 in gastric cancer increases cell proliferation
    Eun Seok Choi, Hanna Lee, Chang Hun Lee, Sung‐Ho Goh · 2016 · FEBS Open Bio
99. Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
    Shohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara, Takamasa Ishino, Keita Ogawa, Miyuki Nakagawa, Kisako Fujiwara, Hidemi Unozawa, Terunao Iwanaga, Takafumi Sakuma et al. · 2021 · JGH Open
100. Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification
     Poonam Sehgal, Pankaj Chaturvedi · 2023 · Cancers